Stonepine Capital Management’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$144K Buy
+116,147
New +$144K 0.14% 53